key: cord-0752843-nd6p1218
authors: Tio, Maria Clarissa; Sparks, Matthew A.; Neyra, Javier A.
title: The International Biomedical Workforce is Critical to Our Response to COVID-19 in the United States
date: 2020-09-29
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2020.09.012
sha: 68683573562a3d8abeb18cf46aab7d01d580dd36
doc_id: 752843
cord_uid: nd6p1218

nan

Coronavirus Disease-19 (COVID-19) is putting a spotlight on the biomedical community, which is at the forefront of the response to the pandemic. Even prior to COVID-19, a physician shortage has been an ongoing issue in the United States (US). The Association of American Medical Colleges (AAMC) predicted that there will be a shortage of 46,900 to 121,900 physicians by 2032. 1 With the onset of the pandemic, the medical community is in an 'all-handson-deck' situation where physicians and other healthcare workers, regardless of specialization, are taking care of patients with COVID-19. While healthcare professionals are at the frontlines in hospitals, clinics and emergency rooms, scientists from across the country are engaged in multifaceted research on SARS-CoV-2 and COVID-19, to understand its epidemiology and pathophysiology, and develop high-throughput diagnostic tools, novel therapeutics, and vaccines to mitigate the disease. The US biomedical workforce that is at the forefront of the fight against COVID-19 is significantly reliant on its international members.

We define the international biomedical workforce as the non-citizen physicians, physicians-intraining, and researchers on immigrant and temporary non-immigrant visas in the US. Foreignborn physicians and surgeons accounted for about 28% of the physician workforce in 2018. 2 Among resident physicians-in-training, almost 15% were not US citizens or permanent residents. 3 Additionally, 34,553 individuals were sponsored by the US Department of State's Exchange Visitor Program in 2018 to train and work in the US on temporary research visas. In New York state, which was hardest hit by the pandemic in the spring, a significant proportion of its physicians are on visas. 4 To underscore this point, the recent changes in immigration policies recognized the importance of international physicians and researchers on visas (J, H1-B, and L), and exempted them from the immigration ban. 5, 6 We believe it is important for US policy makers and government officials to recognize that our nation's successful response to COVID-19 is physicians and scientists from the ban is reassuring, there remains significant concern and anxiety within the medical community. Individuals may be at different stages in the visa/immigration process, and it is uncertain who among the members of the international medical and scientific community would be impacted by the evolving situation. Moreover, the provision states that it exempts those who "perform medical research or other research intended to combat the spread of COVID-19", leaving unclear how this will affect the research community encourage societies of various medical specialties to advocate for international physicians and researchers who are all contributing significantly to address this public health emergency.

The rippling effects of the COVID-19 pandemic extend beyond their devastating health and socio-economic impacts. Consequent effects on evolving travel restrictions, visa sponsorships, and immigration policies can potentially add more strain to the already overburdened biomedical workforce. Since the current complexity of the immigration process is now superimposed upon a global pandemic, it is of utmost importance to ensure our international biomedical workforce is preserved. The US biomedical infrastructure is dependent upon this diverse group of individuals.

We thus call into action the entire medical and scientific community to advocate and protect this vulnerable and vital sector of the US healthcare workforce.

Update The Complexities of Physician Supply and Demand Projections from

Distribution of Physicians With H-1B Visas By State and Sponsoring Employer

Proclamation Suspending Entry of Immigrants Who Present Risk to the U.S. Labor Market During the Economic Recovery Following the COVID-19 Outbreak

Proclamation Suspending Entry of Aliens Who Present a Risk to the U.S. Labor Market Following the Coronavirus Outbreak